NEW YORK (GenomeWeb) – Sophia Genetics said today that it has received ISO 27001 certification from the BSI Group for its internally developed information security management system.
The certification recognizes Sophia's patent pending approach to data encryption that ensures the privacy of genomic data, the company said. It also recognizes the firm's commitment to data security and safeguarding genetic data, Jurgi Camblong, CEO and company co-founder, said in a statement.
Sophia currently provides data analytics, storage, and data processing to more than 30 hospital and laboratories in Europe. It operates redundant servers in secure locations that support these customers' efforts to sample, analyze, and store data from thousands of chronic disease patients.
The company already has ISO 13485 certification for the quality management system it uses for analytics. It has also obtained CE-IVD marking for its genetic testing pipeline and for tests it offers for familial Mediterranean fever, hypercholesterolemia, and cystic fibrosis.